Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Method to Reduce off-Targets in CRISPR/Cas9 System in Plants.

Methods in molecular biology (Clifton, N.J.)·2022
Same author

Mercury can be transported into marine copepod by polystyrene nanoplastics but is not bioaccumulated: An increased risk?

Environmental pollution (Barking, Essex : 1987)·2022
Same author

Electrochemical data mining: from information to knowledge: general discussion.

Faraday discussions·2022
Same author

Advanced nanoelectrochemistry implementation: from concept to application: general discussion.

Faraday discussions·2022
Same author

Comparison of multi-omics results between patients with acute myeloid leukemia with long-term survival and healthy controls.

Annals of translational medicine·2022
Same author

The prognostic factors in acute myeloid leukaemia with double-mutated CCAAT/enhancer-binding protein alpha (CEBPAdm).

British journal of haematology·2022

Related Experiment Video

Updated: Jun 2, 2026

Single-cell Profiling of Developing and Mature Retinal Neurons
10:20

Single-cell Profiling of Developing and Mature Retinal Neurons

Published on: April 19, 2012

Single-Nucleus Profiling Reveals a BBB Senescence Unit Driving AD Pathology in Human Brain.

Yuanwei Zhang1,2, Zhongman Jin3,4, Ruizhen Rao5,6

  • 1College of Life Sciences, University of Chinese Academy of Sciences, Beijing, 100049, China.

Molecular Neurobiology
|June 1, 2026
PubMed
Summary

Cellular senescence drives Alzheimer's disease (AD) by forming a brain barrier (BBB) senescence unit. This unit involves inflammatory signaling and a SPP1-CD44 axis, highlighting senescence as a key AD pathological process.

Keywords:
Alzheimer’s diseaseBlood-brain barrierCellular senescenceNeurovascular unitSPP1-CD44 signaling pathwaySingle-nucleus transcriptomics

More Related Videos

Fluorescence-Activated Nuclei Negative Sorting of Neurons Combined with Single Nuclei RNA Sequencing to Study the Hippocampal Neurogenic Niche
08:16

Fluorescence-Activated Nuclei Negative Sorting of Neurons Combined with Single Nuclei RNA Sequencing to Study the Hippocampal Neurogenic Niche

Published on: October 20, 2022

Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases
09:36

Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases

Published on: June 28, 2019

Related Experiment Videos

Last Updated: Jun 2, 2026

Single-cell Profiling of Developing and Mature Retinal Neurons
10:20

Single-cell Profiling of Developing and Mature Retinal Neurons

Published on: April 19, 2012

Fluorescence-Activated Nuclei Negative Sorting of Neurons Combined with Single Nuclei RNA Sequencing to Study the Hippocampal Neurogenic Niche
08:16

Fluorescence-Activated Nuclei Negative Sorting of Neurons Combined with Single Nuclei RNA Sequencing to Study the Hippocampal Neurogenic Niche

Published on: October 20, 2022

Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases
09:36

Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases

Published on: June 28, 2019

Area of Science:

  • Neuroscience
  • Cell Biology
  • Pathology

Background:

  • Cellular senescence is implicated in Alzheimer's disease (AD) pathogenesis.
  • Its role within the neurovascular unit, particularly the blood-brain barrier (BBB), is not fully understood.

Purpose of the Study:

  • To elucidate the molecular mechanisms of cellular senescence in the AD neurovascular unit.
  • To identify key cellular players and signaling pathways involved in BBB senescence in AD.

Main Methods:

  • Integrated single-nucleus RNA sequencing from 75 human brain samples.
  • Analyzed intercellular communication and gene network interactions.
  • Validated findings using cerebrospinal fluid proteomics data.

Main Results:

  • Identified a coordinated BBB senescence unit comprising astrocytes, pericytes, microglia, and T cells.
  • Revealed inflammatory signaling and maladaptive repair in senescent cells.
  • Uncovered the SPP1-CD44 axis as central to BBB senescence, with SPP1 acting as a hub gene correlated with AD pathology scores.

Conclusions:

  • Cellular senescence is a critical pathological process in AD, specifically impacting the neurovascular unit.
  • The BBB senescence unit, driven by the SPP1-CD44 axis, contributes to AD pathogenesis through sustained inflammation.
  • SPP1 represents a potential therapeutic target and biomarker for AD.